Diabeticheskaya retinopatiya i makulyarnyy otek. Algoritmy diagnostiki i lecheniya klinicheski znachimykh form


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article describes the pathophysiological mechanisms of development of diabetic retinopathy (DR), late sight-threatening vascular complications of diabetes mellitus (DM). The effectiveness of programs for the prevention of diabetes-related blindness depends directly on timely diagnosis and appropriate treatment. This article presents a protocol of ophthalmic management of DM patients, and describes the currently used therapies of DR: laser and surgical (vitrectomy) methods, as well as intravitreal injections of corticosteroids and VEGF inhibitors. Despite the emergence of new medical techniques, laser coagulation of the retina remains the “gold" standard in the prevention of diabetes-related blindness.

Full Text

Restricted Access

About the authors

F. E Shadrichev

References

  1. Астахов Ю.С., Шадричев Ф.Е. Диабетологические центры - новый этап в создании специализированной помощи больным с диабетической ретинопатией // Клиническая офтальмология. М., 2001. № 4. С. 148-53.
  2. Астахов Ю.С., Шадричев Ф.Е., Красавина М.И., Григорьева Н.Н. Современные подходы к лечению диабетического макулярного отека // Офтальмологические ведомости 2009. Т. 2. № 4. С. 59-69.
  3. Астахов Ю.С., Шадричев Ф.Е., Лисочкина А.Б. Лазеркоагуляция сетчатки при лечении диа бетической ретинопатии // Клиническая офтальмология. М., 2000. № 1. Т. 1. С. 15-8.
  4. Шадричев Ф.Е. Протокол офтальмологического ведения больных сахарным диабетом// Офтальмологические ведомости. 2008. Т. 1. № 2. С. 54-61.
  5. Шадричев Ф.Е., Шкляров Е.Б., Григорьева Н.Н. Использование анти-VEGF-терапии в лечении диабетического макулярного отека // Офтальмологические ведомости. 2011. Т. IV. № 1. С. 83-93.
  6. Шадричев Ф.Е., Шкляров Е.Б., Григорьева Н.Н. Применение кортикостероидов в лечении диабетического макулярного отека // Офтальмологические ведомости. 2011. Т IV. № 2. С. 76-88.
  7. Шадричев Ф.Е., Шкляров Е.Б., Григорьева Н.Н. Скрининг диабетической ретинопатии: от офтальмоскопии к цифровому фотографированию // Офтальмологические ведомости. 2009. Т. 2. № 4. С. 19-30.
  8. Ashton N. Retinal neovascularization in health and disease. Am J Ophthalmol 1957;44:7-22.
  9. Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.
  10. Diabetes Control and Complication Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complication Trial. Diabetes 1995;44:968-83.
  11. Beck R.W., Edwards A.R., Aiello L.P., et al. Diabetic Retinopathy Clinical Research Network (DRCR. net). Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009;127:3: 245-51.
  12. Elman M.J., Aiello L.P., Beck R.W., et al. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:6:1064-77.
  13. Diabetic Retinopathy Study Research Group. Four risks factors for severe visual loss in diabetic retinopathy. The third report from the diabetic retinopathy study. Arch Ophthalmol 1979;97;654-55.
  14. Diabetic Retinopathy Study Research Group. Report No 8. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings. Ophthalmology 1981;88:583-600.
  15. Diabetic Retinopathy Research Group. Report No
  16. Indications for photocoagulation treatment of diabetic retinopathy. Int Ophthalmol Clin 1987;27:239-52.
  17. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report No 9. Ophthalmology 1991;98:766-85.
  18. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study (ETDRS) report No 1. Arch Ophthalmol 1985;103:1796-806.
  19. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS report No 2. Ophthalmology 1987;94: 761-74.
  20. Gardner T.W., Lieth E., Antonetti D.A., et al. A new hypothesis on mechanism of retinal vascular permeability in diabetes / In: Diabetic renalretinal syndrome. Ed.: Friedman EA., L'Esperance F.A. 6th ed. // Dordrecht, Netherlands. Kluwer Publisher 1998;169-79.
  21. Haller J.A., Schachat A.P., et al. Update on the pathophisiology, molecular biology, and treatment of macular edema. Advanced studies in ophthalmology 2007;4(7):178-90.
  22. Klein R., Klein B.E.K., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-26.
  23. Klein R., Klein B.E.K., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32.
  24. Klein R., Klein B.E.K., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XI. The incidence of macular edema. Ophthalmology 1989;96:1501-10.
  25. Larsen M., Dalgaard P., Lund-Andersen H. Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide. Graefes Arch Klin Exp Ophthalmol 1991;229:350-57.
  26. Massin P., Bandello F., Garweg J.G., et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care; 2010:33(11): 2399-405.
  27. Mitchell P., Bandello F., Schmidt-Erfurth U. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118(4):615-25.
  28. Michaelson I.C. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948;68:137-80.
  29. Porta M., Kohner E.M., Screening for diabetic retinopathy in Europe. Diabetic Medicine 1991;8:197-98.
  30. WHO. Prevention of blindness from diabetes mellitus" // Report of a WHO consultation in Geneva 9-11 November 2005. Switzerland. WHO press 2005;39.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies